Scientists synthesized compounds that inhibited the 2-AG-producing enzyme DAGLalpha at nanomolar concentrations with high selectivity, creating precision tools for studying endocannabinoid signaling.
Read this if you're interested in the chemistry behind developing tools to manipulate the endocannabinoid system.
New DAGLalpha inhibitors 20x more potent than parent compound with 23-375 fold selectivity
What the researchers found
Researchers synthesized 21 analogues of tetrahydrolipstatin (THL, the active ingredient in the weight-loss drug orlistat) and tested them as inhibitors of 2-AG metabolism.
Three compounds (11, 13, and 15) inhibited DAGLalpha (the enzyme that produces 2-AG) with IC50 values below 50 nanomolar, making them 20 times more potent than the parent compound THL. Critically, they were 23- to 375-fold selective for DAGLalpha over MAGL (which breaks down 2-AG), CB1/CB2 receptors, and FAAH.
One compound (8) was a potent inhibitor of MAGL-like activity (IC50 = 0.41 micromolar) with approximately 7-fold selectivity over other targets.
These selective tools allowed researchers to separately manipulate 2-AG production and degradation, enabling more precise studies of endocannabinoid function.
Why it matters
Selective pharmacological tools are essential for understanding which aspects of endocannabinoid signaling produce specific biological effects. These compounds allowed researchers to ask whether reducing 2-AG production versus enhancing it by blocking breakdown produces different outcomes.
The numbers in context
Compounds 11, 13, 15: DAGLalpha IC50 < 50 nM (vs. THL IC50 = 1 micromolar). Selectivity: 23-375 fold vs. MAGL, CB1/CB2, FAAH. Compound 8: MAGL IC50 = 0.41 micromolar, 7-fold selective.
How the study worked
Medicinal chemistry study synthesizing 21 THL analogues. Compounds were tested against DAGLalpha, MAGL, CB1, CB2, and FAAH in standardized biochemical assays to determine potency and selectivity.
What this study cannot tell us
These are tool compounds, not drug candidates. In vitro potency and selectivity may not translate to in vivo utility. No behavioral or physiological testing was reported. Long-term safety profiles were not assessed.
How to read the evidence
This is a medicinal chemistry study producing research tools. It provides robust in vitro data but no biological or clinical evidence.
When this study was published
Published in 2008. DAGLalpha and MAGL inhibitors have since become standard research tools, and some MAGL inhibitors have entered clinical trials.
The bigger picture
These research tools contributed to the understanding that the endocannabinoid system can be modulated at multiple points (synthesis, degradation, receptor) with different therapeutic profiles. This precision approach has guided the development of endocannabinoid-targeting medications.
Questions still open
- What happens when 2-AG synthesis is selectively blocked in vivo? Could DAGLalpha inhibitors have therapeutic applications in conditions with endocannabinoid excess?
Common questions
What is DAGLalpha?
Why does selectivity matter?
Read the original research
Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.
Journal of medicinal chemistry, 51(21), 6970-9
Citation
Ortar, Giorgio; Bisogno, Tiziana; Ligresti, Alessia; Morera, Enrico; Nalli, Marianna; Di Marzo, Vincenzo. (2008). Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.. Journal of medicinal chemistry, 51(21), 6970-9. https://doi.org/10.1021/jm800978m
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)